126 related articles for article (PubMed ID: 34247052)
1. Anti-cancer immunoprotective effects of immunization with hydatid cyst wall antigens in a non-immunogenic and metastatic triple-negative murine mammary carcinoma model.
Shakibapour M; Kefayat A; Reza Mofid M; Shojaie B; Mohamadi F; Maryam Sharafi S; Mahmoudzadeh M; Yousofi Darani H
Int Immunopharmacol; 2021 Oct; 99():107955. PubMed ID: 34247052
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal Antibodies Production Against a 40KDa Band of Hydatid Cyst Fluid.
Sharafi SM; Shirzad H; Khanahmad H; Ataei B; Darani HY
Recent Pat Biotechnol; 2018; 12(1):57-64. PubMed ID: 28317492
[TBL] [Abstract][Full Text] [Related]
3. Immunization using male germ cells and gametes as rich sources of cancer/testis antigens for inhibition of 4T1 breast tumors' growth and metastasis in BALB/c mice.
Safavi A; Kefayat A; Ghahremani F; Mahdevar E; Moshtaghian J
Int Immunopharmacol; 2019 Sep; 74():105719. PubMed ID: 31272065
[TBL] [Abstract][Full Text] [Related]
4. Immunoprotective effect of an in silico designed multiepitope cancer vaccine with BORIS cancer-testis antigen target in a murine mammary carcinoma model.
Mahdevar E; Kefayat A; Safavi A; Behnia A; Hejazi SH; Javid A; Ghahremani F
Sci Rep; 2021 Nov; 11(1):23121. PubMed ID: 34848739
[TBL] [Abstract][Full Text] [Related]
5. Identifying the Most Effective Hydatid Cyst Fluid Fraction for Anticancer Vaccination of 4T1 Breast Tumor-Bearing Mice.
Daneshpour S; Rostamirad S; Kefayat A; Mofid M; Safavi A; Darani HY
Int J Prev Med; 2019; 10():143. PubMed ID: 31516684
[TBL] [Abstract][Full Text] [Related]
6. Immunization with Hydatid Cyst Wall Antigens Can Inhibit Breast Cancer through Changes in Serum Levels of Th1/Th2 Cytokines.
Shakibapour M; Shojaie B; Yousofi Darani H
Int J Prev Med; 2020; 11():189. PubMed ID: 33815713
[TBL] [Abstract][Full Text] [Related]
7. Specificity of the IgG response in mice and human breast cancer patients following immunization against synthetic sialyl-Tn, an epitope with possible functional significance in metastasis.
Longenecker BM; Reddish M; Koganty R; MacLean GD
Adv Exp Med Biol; 1994; 353():105-24. PubMed ID: 7527178
[TBL] [Abstract][Full Text] [Related]
8. Production of mouse monoclonal anti-idiotypic antibodies specific to epitopes of tumor-associated mucin TAG-12.
Schmitt H; Khazaeli MB; Rodenburg CM; Kaul S; Bastert G
Hybridoma; 1994 Oct; 13(5):389-96. PubMed ID: 7532153
[TBL] [Abstract][Full Text] [Related]
9. Effect of hydatid cyst antigens on inhibition of melanoma cancer growth in mouse model.
Rostami Rad S; Daneshpour S; Mofid MR; Andalib A; Eskandariyan A; Yousofi Darani H
Cell Mol Biol (Noisy-le-grand); 2018 Sep; 64(12):1-5. PubMed ID: 30301493
[TBL] [Abstract][Full Text] [Related]
10. Towards an idiotype vaccine against mammary tumors. Induction of an immune response to breast cancer-associated antigens by anti-idiotypic antibodies.
Smorodinsky NI; Ghendler Y; Bakimer R; Chaitchuk S; Keydar I; Shoenfeld Y
Eur J Immunol; 1988 Nov; 18(11):1713-8. PubMed ID: 2849550
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of co-immunization with the DNA and peptide vaccines containing SYCP1 and ACRBP epitopes in a murine triple-negative breast cancer model.
Safavi A; Kefayat A; Mahdevar E; Ghahremani F; Nezafat N; Modarressi MH
Hum Vaccin Immunother; 2021 Jan; 17(1):22-34. PubMed ID: 32497486
[TBL] [Abstract][Full Text] [Related]
12. Murine monoclonal anti-idiotypic antibody as a surrogate antigen for human Her-2/neu.
Baral R; Sherrat A; Das R; Foon KA; Bhattacharya-Chatterjee M
Int J Cancer; 2001 Apr; 92(1):88-95. PubMed ID: 11279611
[TBL] [Abstract][Full Text] [Related]
13. Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice.
Wang B; Zaidi N; He LZ; Zhang L; Kuroiwa JM; Keler T; Steinman RM
Breast Cancer Res; 2012 Mar; 14(2):R39. PubMed ID: 22397502
[TBL] [Abstract][Full Text] [Related]
14. Induction of Humoral and Cellular Immune Responses in Mice by Multiepitope Vaccines Composing of Both T and B Lymphocyte Epitopes of MAGE-A3 which are Recombined into HBcAg.
Chen Q; Li W; Wang P; Shao H; Ding Y; Wang W; Cen D; Cai Y; Xue X; Zhang L; Zhu G
Protein Pept Lett; 2017; 24(10):947-954. PubMed ID: 28641561
[TBL] [Abstract][Full Text] [Related]
15. Redirecting adaptive immunity against foreign antigens to tumors for cancer therapy.
Hu W; Davis JJ; Zhu H; Dong F; Guo W; Ang J; Peng H; Guo ZS; Bartlett DL; Swisher SG; Fang B
Cancer Biol Ther; 2007 Nov; 6(11):1773-9. PubMed ID: 17986853
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor immunity induced by an anti-idiotype antibody mimicking human Her-2/neu.
Mohanty K; Saha A; Pal S; Mallick P; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
Breast Cancer Res Treat; 2007 Jul; 104(1):1-11. PubMed ID: 17004107
[TBL] [Abstract][Full Text] [Related]
17. A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model.
Song C; Zheng XJ; Liu CC; Zhou Y; Ye XS
Oncotarget; 2017 Jul; 8(29):47330-47343. PubMed ID: 28537884
[TBL] [Abstract][Full Text] [Related]
18. Tumours can act as adjuvants for humoral immunity.
Brown DM; Fisher TL; Wei C; Frelinger JG; Lord EM
Immunology; 2001 Apr; 102(4):486-97. PubMed ID: 11328383
[TBL] [Abstract][Full Text] [Related]
19. Antigenic epitopes of three tumor-associated antigens of well-differentiated squamous cell carcinoma of the larynx for use in monitoring patients in specific active immunochemotherapy trials.
Hollinshead AC
Cancer Detect Prev; 1987; 10(3-4):153-8. PubMed ID: 2436778
[TBL] [Abstract][Full Text] [Related]
20. Experimental and clinical studies with active specific immunotherapy.
Livingston PO
Prog Clin Biol Res; 1989; 288():309-21. PubMed ID: 2654953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
